论文部分内容阅读
非淋菌性尿道炎（NGU）的发病率在性传播疾病（STD）中居于首位[1]，积极有效的治疗是控制NGU的主要措施之一。林可霉素是近来投入国内应用的非大环内脂类抗生素，为了观察其对NGU的疗效，我们于1997年10月一1997年12月进行了林可霉素与红霉素比较的前瞻性研究，现报告如下。1
The incidence of non-gonococcal urethritis (NGU) is highest among STDs [1]. Active and effective treatment is one of the major measures to control NGU. Lincomycin is a non-macrocyclic lipids antibiotic recently introduced into domestic applications. In order to observe its efficacy on NGU, we conducted a prospective comparison between lincomycin and erythromycin from October 1997 to December 1997 Sexual research, report as follows now. 1